Target intelligence / Profile preview

Acyl-CoA oxidase (ACOX)

Target
ACOX
Molecular classification
Enzyme, Oxidoreductase, Peroxisomal protein, Flavoprotein (FAD-dependent)
01

Overview

Acyl-CoA oxidase is a peroxisomal flavoprotein and the first committed enzyme in peroxisomal β-oxidation, responsible for the desaturation of acyl-CoA substrates, transferring electrons to FAD and then to molecular oxygen to form hydrogen peroxide. This distinguishes it from acyl-CoA dehydrogenase in mitochondria, which routes electrons to the electron transport chain. Subtypes with defined substrate specificities exist: e.g., ACOX1 for straight-chain fatty acids, ACOX2 for branched-chain fatty acids, and ACOX3 for bile acid CoA derivatives. Deficiency or dysfunction causes severe metabolic and neurologic disease, particularly due to VLCFA accumulation and secondary inflammation/degeneration in nervous tissue. The enzyme has a well-resolved crystal structure and is evolutionarily conserved among eukaryotes.

Other names
fatty acyl-CoA oxidaseacyl coenzyme A oxidasefatty acyl-coenzyme A oxidaseacyl-CoA:oxygen 2-oxidoreductase
02

Mechanism of action

Drugs (notably experimental) that influence Acyl-CoA oxidase typically act by modulation of gene expression (e.g., PPAR agonists), enzyme inhibition or activation, or by affecting peroxisomal function in general.

03

Biological functions

Fatty acid β-oxidation (peroxisomal)Lipid catabolismGeneration of hydrogen peroxidePolyunsaturated fatty acid biosynthesisSignal transduction (in plants and some metabolic pathways)
04

Disease associations

Peroxisomal disorders (acyl-CoA oxidase deficiency, Zellweger spectrum disorders)Neurodegenerative disease (myelin breakdown from VLCFA accumulation)Metabolic disease (impaired β-oxidation)Inflammation (secondary to VLCFA accumulation)Aging (altered fatty acid metabolism affects aging pathways)Other (cancer, cardiac metabolism—context-specific)
05

Safety considerations

Hydrogen peroxide generation (may cause oxidative damage if peroxisomal catalase is deficient)Inhibition can lead to VLCFA accumulation and cell toxicity
06

Biomarkers

Very long-chain fatty acids (VLCFAs) in plasma/tissue (used to diagnose peroxisomal disorders)Acetyl-CoA/β-oxidation intermediates

Beyond the preview

Go deeper on Acyl-CoA oxidase (ACOX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acyl-CoA oxidase (ACOX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call